CryoCell International Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.8% | +9.7% | +9.8% | +15.1% | +8.9% | -2.1% | -7.3% | +5.0% | +3.3% | +2.0% | -1.3% | |
| – | 0.0% | +2.6% | +16.4% | +27.0% | +17.5% | -3.8% | -6.9% | -2.2% | -4.0% | -5.9% | -7.2% | |
| – | +6.7% | +12.2% | +7.5% | +10.8% | +5.3% | -1.3% | -7.4% | +8.3% | +6.3% | +5.0% | +0.6% | |
| – | -28.9% | +16.0% | -22.5% | +123.1% | -67.2% | -20.9% | +109.1% | +671.6% | +204.4% | +6.1% | -69.7% | |
| – | +1.1% | +18.8% | -8.4% | +16.0% | -4.7% | -4.0% | +2.3% | +6.5% | +9.9% | +8.2% | -1.6% | |
| – | +0.1% | +35.1% | -19.3% | +13.4% | +7.9% | -17.3% | +14.8% | +10.3% | +100.9% | -41.6% | -5.9% | |
| – | +48.1% | -85.2% | +1,054.6% | +3.7% | -2.4% | +51.3% | -47.6% | +0.2% | -405.7% | – | +39.1% | |
| – | +13.2% | -27.3% | +37.5% | +18.8% | +10.1% | -9.4% | -10.7% | +10.4% | -18.7% | +50.8% | +10.8% | |
| – | +40.2% | -361.2% | – | -0.2% | -6.3% | +48.6% | -48.2% | +27.1% | -502.7% | – | -183.3% | |
| – | -5,893.8% | – | – | +241.8% | -75.4% | +28.5% | -62.7% | +3.8% | -801.8% | – | -96.2% | |
| – | +1,364.2% | -116.3% | – | -136.9% | – | +58.2% | -42.5% | +33.0% | -443.6% | – | -704.2% | |
| – | +13.1% | -150.0% | – | +6.3% | +0.3% | +31.4% | -26.4% | +25.1% | -256.6% | – | -22.9% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.